These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4810021)

  • 1. Effect of procainamide on fibrillation threshold of normal and ischemic ventricles.
    Yoon MS; Han J; Goel BG; Creamer P
    Am J Cardiol; 1974 Feb; 33(2):238-42. PubMed ID: 4810021
    [No Abstract]   [Full Text] [Related]  

  • 2. Ventricular vulnerability during acute coronary occlusion.
    Han J
    Am J Cardiol; 1969 Dec; 24(6):857-64. PubMed ID: 4188211
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of procainamide on the induction of ventricular fibrillation by sequential ventricular stimulation.
    Murakawa Y; Sugimoto T
    Jpn Circ J; 1987 Feb; 51(2):203-7. PubMed ID: 3599365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymorphic ventricular tachycardia and ventricular fibrillation due to N-acetyl procainamide.
    Herre JM; Thompson JA
    Am J Cardiol; 1985 Jan; 55(1):227-8. PubMed ID: 2578244
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of transmyocardial punctures on left ventricular performance after coronary occlusion in the acute experiment.
    Bĕlobrádek Z; van der Meer JJ; Reneman RS; Wieberdink J
    Thorax; 1972 Mar; 27(2):223-7. PubMed ID: 5034600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of excitability on the ventricular fibrillation threshold in dogs.
    Gaum WE; Elharrar V; Walker PD; Zipes DP
    Am J Cardiol; 1977 Dec; 40(6):929-35. PubMed ID: 930840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary endothelin-1 infusion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effects.
    Kiss O; Zima E; Soós P; Kékesi V; Juhász-Nagy A; Merkely B
    Life Sci; 2004 Jun; 75(5):537-48. PubMed ID: 15158364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derangements of myocardial metabolism preceding onset of ventricular fibrilliation after coronary occlusion.
    Corday E; Heng MK; Meerbaum S; Lang TW; Farcot JC; Osher J; Hashimoto K
    Am J Cardiol; 1977 May; 39(6):880-9. PubMed ID: 16479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations on factors affecting local forces in the left ventricular wall during acute myocardial ischemia.
    Schelbert HR; Covell JW; Burns JW; Maroko PR; Ross J
    Circ Res; 1971 Sep; 29(3):306-16. PubMed ID: 5093290
    [No Abstract]   [Full Text] [Related]  

  • 11. Ventricular refractoriness during acute myocardial ischaemia and its relationship to ventricular fibrillation.
    Russell DC; Oliver MF
    Cardiovasc Res; 1978 Apr; 12(4):221-7. PubMed ID: 657178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of production of ventricular fibrillation in coronary angiography.
    Simon AL; Shabetai R; Lang JH; Lasser EC
    Am J Roentgenol Radium Ther Nucl Med; 1972 Apr; 114(4):810-6. PubMed ID: 5026245
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocardial boring for the ischemic heart.
    Wakabayashi A; Little ST; Connolly JE
    Arch Surg; 1967 Nov; 95(5):743-52. PubMed ID: 6053955
    [No Abstract]   [Full Text] [Related]  

  • 14. Distinctive time course of ventricular vulnerability to fibrillation during and after release of coronary ligation.
    Battle WE; Naimi S; Avitall B; Brilla AH; Banas JS; Bete JM; Levine HJ
    Am J Cardiol; 1974 Jul; 34(1):42-7. PubMed ID: 4835752
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the mechanics of ventricular contractions in the prefibrillation period].
    Takác M; Kalitza A; Orco J; Kollár J
    Bratisl Lek Listy; 1968 Nov; 50(5):638-45. PubMed ID: 4237253
    [No Abstract]   [Full Text] [Related]  

  • 16. Bretylium tosylate for suppression of ventricular fibrillation after experimental myocardial infarction.
    Bacaner MB; Schrienemachers D
    Nature; 1968 Nov; 220(5166):494-6. PubMed ID: 5686170
    [No Abstract]   [Full Text] [Related]  

  • 17. Atropine-induced ventricular ectopic arrhythmias and fibrillation.
    Page CP; Deaton WJ; Warren BH; Hoff GE
    Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):469-77. PubMed ID: 5968524
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental studies of coronary insufficiency. I. Changes in myocardial contractility in the ischemic area of the ventricle following acute coronary occlusion.
    Yoshida S
    Jpn Circ J; 1969 Nov; 33(11):1253-8. PubMed ID: 5395969
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventricular endocardial potentials after experimental coronary artery occlusion in dogs.
    Chatterjee K; Rouse W
    Am Heart J; 1971 Sep; 82(3):352-61. PubMed ID: 5565424
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of the autonomic nervous system on the resistance of heart ventricles to fibrillation].
    Stoliarchuk AA; Vasil'eva SA; Storozhuk BG
    Fiziol Zh (1978); 1990; 36(3):73-6. PubMed ID: 2394253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.